Synthesis, Physico Chemical and Spectral Studies of Mercury Complex of Glibenclamide; An Oral Antidiabetic Drug
S. A.Iqbal*, Sibi Jose¹ and Ishaq Zaafarany²
*Department of Chemistry, Crescent College of Technology, Bhopal - 462 006 (India).
¹Department of Chemistry, Sadhu Vaswani College, Bairagarh, Bhopal - 462 001 (India).
²Department of Chemistry, Umm-Al-Qura University, Makkah (Saudi Arabia).
Glibenclamide is a current, potent hypoglycemic agent used in NIDDM (non-insulin dependent diabetes mellitus). Metal complexs of glibenclamide has been synthesised by reaction with mercury (II) in the form of its chloride. The conductometric titration using monovariation method indicates that complex is non-ionic and ML2 type which was further confirmed by Job’s method of continuous variation as modified by Turner and Anderson. Analytical data agrees with the molecular formula (C23H28ClN3O5S)2 Hg structure of the complex was assigned as tetrahedral in which ligand molecules lies horizontally joining the central mercury atom. Infrared spectral and molar conductance data confirm the co-ordination of sulphonyl oxygen on one side and enolic oxygen attached from other side with the metal ion. Structure assigned to the complex is supported by analytical data and IR spectra.
KEYWORDS:Synthesis; antidiabetics; glibenclamide; IR spectra
Download this article as:Copy the following to cite this article: Iqbal S. A, Jose S, Zaafarany I. Synthesis, Physico Chemical and Spectral Studies of Mercury Complex of Glibenclamide; An Oral Antidiabetic Drug. Orient J Chem 2012;28(1). |
Copy the following to cite this URL: Iqbal S. A, Jose S, Zaafarany I. Synthesis, Physico Chemical and Spectral Studies of Mercury Complex of Glibenclamide; An Oral Antidiabetic Drug. Orient J Chem 2012;28(1). Available from: http://www.orientjchem.org/?p=24110 |
Introduction
Man has been in continued search for chemotherapeutic agents right from the earliest times, about 2000 B.C. or even earlier. As a result of this research several naturally occurring substances, plant materials and minerals including Arsenic, Mercury, Bismuth, Gold and Silver as metals or as their salts have been used for several thousand years, especially in Ayurveda and Unani system of medicines. In the early part of the twentieth century, organo-metallic compounds emerged as important agents in the treatment of syphilis, tropical diseases etc1-3. Chemically arsenic, antimony and bismuth belong to the same family and have some common pharmacological actions. Mercurials comparatively, still hold importance in medicine and organic mercurials are used as divretics4. The discovery of vitamin B12 and copper phthalocyanine has given impetus to the development of metal complexes with organic ligands. A survey of literature reveals that metal complexes of some drugs have been found to be more potent than the drug alone therefore in continuation of our previous work 5-10 on metal complexes of oral antidiabetic agents of hypoglycemic activity, the synthesis and structural studies of glibenclamide-Hg complex is described here. Glibenclamide (Euglucon, 1-(4-(2(chloro-2-methoxybenzamide0) ethyl) – benzene sulphonyl)-3-cyclo hexyl urea, is a sulphonyl urea derivative having melting point 169-1740C is a white or almost white crystalline orderless powder, practically without taste, insoluble in water and soluble in ethanol, methanol and in alkalisolution. It dissolves in diethyl ether also. Glibenclamide is a second generation oral hypoglycemic agent which is more potent than those of first group11 and is used to assist in the control of mild to moderately severe type (II) diabetes mellitus. Complexation of sulphonyl urea with lighter transition metals has been studied in detail12-13. A perusal of available literature shows that many drugs possessed modified pharmacological and toxicological properties when administered in the form of metallic complexes.
Experimental Ligand-Metal ratio
Pure glibenclamide (1) Trade name, Euglucon a sulphonyl urea derivative is supplied by Aventis pharma Ltd; Goa in powdered form. 0.005 M drug and mercuric (II) chloride (HgCl2) 0.01M (Analar grade) were prepared in purified 80% ethanol. Glibenclamide (20ml) was diluted to 200ml and titrated conductometrically against mercuric chloride at 27 10C.
Formation of 2:1 (L2M) ratio was also confirmed by Job’s method14 of continuous variation as modified by Turner and Anderson15 using conductance as index property. Form these value, the stability constant (logk) and free energy change (- F) were also calculated16-17. (Table 1 and 2., Fig I & II).
Synthesis of Complex
The chemicals used in this synthesis were all of analytical grade. A weighed quantity of glibenclamide (2 mol) was dissolved in minimum quantity of 80% ethanol. The mercuric (II) chloride solution was prepared by dissolving it separately in the same solvent. Lignd solution was added slowly with constant stirring into the solution of metallic salt at room temprature maintaining the pH between 6.2 to 6.9 by adding dilute NaOH solution. On refluxing the mixture for 3h at 800C on cooling, the complex separated out which was filtered off, washed well with ethanol (80%) and finally dried in vacuum and weighed. The elemental analysis of the isolated complex was carried out using the reported methods18-19. In the comlex, mercury was estimated gravimetrically as sulphide, nitrogen by kjeldhal method and sulphur by massenger’s method, using modified digestion mixture20-21. The IR spectrum of the ligand as well as of the complex was recorded on Perkin Elmer spectrophotometer RX1(4000-450 cm-1) CDRI Lucknow.
Glibenclamide With Mercuric Chloride
(JOB’S METHOD)
Glibenclamide – 0.005 M HgCl2 – 0.005 M
Solvent – 90% Ethanol Temperature 27.5 10C
Mole metal ligand ratio |
Conductance X10-4Mhos M:S S:L M:L C1 C2 C3 |
Conductance X10-4Mhos C1+C2-C3 |
Corrected Δconductance X10-4Mhos |
||
0:12 |
0.22 |
1.66 |
1.84 |
0.04 |
0.00 |
1:11 |
0.26 |
1.55 |
1.69 |
0.12 |
0.08 |
2:10 |
0.35 |
1.51 |
1.65 |
0.21 |
0.17 |
3:9 |
0.39 |
1.42 |
1.56 |
0.25 |
0.21 |
4:8 |
0.43 |
1.30 |
1.40 |
0.33 |
0.29 |
5:7 |
0.47 |
1.19 |
1.36 |
0.30 |
0.26 |
6:6 |
0.50 |
1.40 |
1.30 |
0.24 |
0.20 |
7:5 |
0.53 |
0.89 |
1.21 |
0.21 |
0.17 |
8:4 |
0.56 |
0.79 |
1.16 |
0.19 |
0.15 |
9:3 |
0.60 |
0.64 |
1.10 |
0.14 |
0.10 |
10:2 |
0.64 |
0.50 |
1.04 |
0.10 |
0.05 |
11:1 |
0.69 |
0.36 |
0.97 |
0.08 |
0.03 |
12:0 |
0.73 |
0.20 |
0.88 |
0.05 |
0.00 |
Glibenclamide With Mercuric Chloride
(JOB’S METHOD)
Glibenclamide – 0.002 M HgCl2 – 0.002 M
Solvent – 90% Ethanol Temperature 27.5 10C
Mole metal ligand ratio |
Conductance X10-4Mhos M:S S:L M:L C1 C2 C3 |
Conductance X10-4Mhos C1+C2-C3 |
Corrected Δconductance X10-4Mhos |
||
0:12 |
0.24 |
1.32 |
1.53 |
0.03 |
0.00 |
1:11 |
0.28 |
1.25 |
1.43 |
0.10 |
0.07 |
2:10 |
0.31 |
1.19 |
1.36 |
0.14 |
0.11 |
3:9 |
0.34 |
1.15 |
1.28 |
0.21 |
0.18 |
4:8 |
0.37 |
1.07 |
1.18 |
0.26 |
0.23 |
5:7 |
0.40 |
0.98 |
1.16 |
0.22 |
0.19 |
6:6 |
0.43 |
0.89 |
1.12 |
0.20 |
0.17 |
7:5 |
0.47 |
0.75 |
1.07 |
0.15 |
0.12 |
8:4 |
0.50 |
0.63 |
1.00 |
0.13 |
0.10 |
9:3 |
0.54 |
0.50 |
0.93 |
0.11 |
0.08 |
10:2 |
0.57 |
0.39 |
0.86 |
0.10 |
0.07 |
11:1 |
0.61 |
0.29 |
0.84 |
0.06 |
0.04 |
12:0 |
0.65 |
0.14 |
0.76 |
0.03 |
0.00 |
This work is licensed under a Creative Commons Attribution 4.0 International License.